Immunostaining for Lyve1 (marker of differentiated LSECs) was reduced in Vcam1fl/fl mice and restored in Vcam1Δend mice in both NASH and liver fibrosis models. This evidence concerns the gene LYVE1 and metabolic dysfunction-associated steatohepatitis.